publication date: Dec. 19, 2014

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say


The Cancer Letter asked leaders of science and cancer advocacy groups to comment on the half-percent increases in federal funding for NIH and NCI in fiscal 2015, and on the prospects of science funding when Republicans take control of Congress in January.

Their responses follow:


Peter Paul Yu, president of the American Society of Clinical Oncology

The federal budget process over the past decade has created severe instability for medical research funding.

If we are going to build on the major progress that we have made in every area of cancer care, Congress must provide predictable increases in funding for the National Institutes of Health and the National Cancer Institute that at least keep pace with the rate of biomedical inflation.

ASCO looks forward to working with this Congress and will continue to urge members on both sides of the aisle to provide long-term financial support to our nation’s cancer research infrastructure that corrects years of underfunding.


Richard Schilsky, chief medical officer of ASCO

We’re encouraged that Congress passed an omnibus budget rather than another short-term continuing resolution, and we appreciate the hard work of many lawmakers to ensure that the bill includes an increase for NIH and NCI.

However, this small increase isn’t enough to build a robust future for America’s cancer research enterprise and combat the continued decreasing purchasing power of the NCI.


Jon Retzlaff, managing director of science policy and government affairs at the … Continue reading 40-47 Half-Percent Raise Is Not Enough

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.